The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPolar Capital Regulatory News (POLR)

Share Price Information for Polar Capital (POLR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 550.00
Bid: 547.00
Ask: 550.00
Change: 6.00 (1.10%)
Spread: 3.00 (0.548%)
Open: 540.00
High: 550.00
Low: 538.00
Prev. Close: 544.00
POLR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Interim Results

4 Dec 2013 07:00

RNS Number : 6256U
Polar Capital Holdings PLC
04 December 2013
 



POLAR CAPITAL HOLDINGS plc ("Polar Capital" or "the Company")

Interim results for the six months ended 30 September 2013

 

 

4 December 2013

 

Financial Highlights

· Net inflows in the six month period ended 30 September 2013 of US$3.2bn despite unpredictable markets

· Assets under Management ("AUM") at 30 September 2013 up 58% to US$11.4bn (31 March 2013: US$7.2bn)

· Core operating profit excluding performance fees up 147% to £10.4m (30 September 2012: £4.2m)

· Profit before share-based payments and amortisation of intangibles of £10.6m (30 September 2012: £4.6m)

· Pre-tax profit of £10.1m (30 September 2012: £3.8m)

· Basic earnings per share 9.53p (30 September 2012: 3.64p) and adjusted* diluted earnings per share 8.77p (30 September 2012: 4.14p)

· Interim dividend per ordinary share of 4.0p declared (2012:2.0p) to be paid in January 2014

· Shareholders' funds of £56.8m (31 March 2013: £53.8m) including cash and investments of £56.7m (31 March 2013: £62.2m)

* Adjusted to exclude cost of share-based payments and amortisation/impairment of intangibles

 

Corporate Highlights

Launch of three new funds since 31 March 2013

· Long only Biotechnology UCITS fund launched in November 2013

· The Global Convertible Fund launched in September 2013

· Our third investment trust, The Global Financials Trust, which raised £153m in July 2013

 

Tim Woolley, Chief Executive Officer, commented:

The Company's growth rate over recent quarters has been exceptional and indeed over the last four years our AUM has increased more than fivefold. Our growth rate will undoubtedly slow over the coming quarters and years. In the very near term our growth rate will be heavily influenced by the direction of the Japanese market and fund flows into or out of our Japanese funds given the percentage of overall assets these funds now represent. Over the longer term there remains significant opportunity for further growth in assets and profits if we continue to deliver on investment performance, client service and operational excellence and if global equity markets remain supportive.

 

 

For further information please contact:

Polar Capital +44 (0)20 7227 2700

Tim Woolley (CEO)

John Mansell (CFO)

 

Canaccord Genuity - Nomad and Broker +44 (0)20 7523 8000

Martin Green

Cameron Duncan

 

 

F T I Consulting +44 (0)20 7269 7132

Neil Doyle

Jack Hickey

 

 

Polar Capital Holdings plc is a specialist investment management company offering professional and institutional investors a range of geographical and sector funds. The Company's investment strategies have a fundamental research driven approach. The Company has long only and alternative funds in its product range.

 

Founded in 2001, Polar currently has 94 employees of whom 46 are investment professionals managing 22 funds, and 7 managed accounts. These funds have combined assets under management of US$11.4bn as at 30 September 2013 (30 March 2013: US$7.2bn)

 

The Company is AIM quoted following its IPO in February 2007. Consistent with the Company's founding strategy of fostering an equity culture amongst its employees and providing high levels of transparency to clients, 32% of the equity is currently held by Directors, founders and employees.

 

Assets by fund / strategy

30 September 2013

US$m

31 March

2013

US$m

 30 September 2012

US$m

Technology

1,488

1,255

1,321

Technology Trust plc

923

823

815

Global Technology UCITS Fund

565

432

506

Japan

4,914

2,389

1,421

Japan UCITS Fund*

4,861

2,375

1,421

Japan Alpha UCITS Fund

53

14

-

UK†

293

261

295

UK Absolute Return UCITS Fund*

41

36

37

UK Managed Account

252

225

258

Europe

704

700

654

European Forager Alternative Fund

548

528

505

European Conviction Alternative Fund

156

172

149

Healthcare

794

616

440

Global Healthcare Growth & Income Trust plc

252

228

195

Healthcare Opportunities UCITS Fund

542

388

245

Financials

975

669

526

Asian Financials UCITS Fund

55

73

53

Global Insurance UCITS Fund

559

485

381

Financials Income UCITS Fund

90

89

77

Financial Opportunities UCITS Fund

24

22

15

Global Financials Trust plc

247

-

-

Global Emerging Markets

749

571

234

Emerging Markets Growth UCITS Fund*

291

195

117

Emerging Markets Income UCITS Fund

458

376

117

Convertible

73

40

41

ALVA Global Convertible Alternative Fund*

68

40

41

Global Convertible UCITS Fund

5

-

-

North American UCITS Fund

1,321

637

343

European Market Neutral

64

59

27

European Market Neutral Alternative Fund

19

18

19

European Market Neutral UCITS Fund

45

41

8

Global Alpha UCITS Fund

33

11

-

Total

11,408

7,208

5,302

*Including managed accounts run off the same strategy † The UK Fund was closed on 8 November 2013

Analysis of Changes in Asset Types for the six months to 30 September 2013

Long

US$m

Alternative Funds

US$m

Total

US$m

Total assets as at 31 March 2013

6,371

837

7,208

Net subscriptions/(redemptions) from ongoing business

3,239

6

3,245

Performance and currency movements

916

39

955

Total assets at 30 September 2013

10,526

882

11,408

 

Analysis of AUM by Business Unit and Type of Funds as at 30 September 2013

Technology

13%

Long only funds

92%

Japan

43%

Alternative funds

8%

UK

2%

100%

Europe

6%

Healthcare

7%

Financials

9%

Global Emerging Markets

6%

Global Convertibles

1%

North American

12%

European Market Neutral

1%

Global Alpha

-

100%

 

 

Chief Executive's Statement

 

I am pleased to report further significant progress over the first six months of our financial year. Our assets under management ("AUM") have increased substantially over the period, reaching $11.4bn at the end of September. This is an increase of 58% over the year end level and an increase of 115% from this time last year. Our balance sheet remains strong and the key metric of core profitability increased 147% over the comparable period last year as set out below:

Six months to

30 September 2013

Six months to

30 September 2012

Core operating profit

£10.4m

£4.2m

Performance fee profit

-

-

Finance income

£0.2m

£0.4m

Profit before share based payments, amortisation, impairment and tax

£10.6m

£4.6m

 

Profit before tax increased significantly as a result of the increase in core profit with finance income somewhat lower than in the comparable period last year. We can currently report that, on a mark to market basis, the quantum of performance fees receivable at the half year exceeds the level of performance fees receivable on the same basis last year.

Our world class Japanese team has received the majority of our inflows over this period as client interest in Japan has continued to increase following the various reforms introduced by Prime Minister Abe starting last November.

We have also seen significant inflows into a number of other strategies including North America, Healthcare, Emerging Markets and Financials.

Following the departure of our UK manager we now have ten teams in place, giving us scope to accommodate a further two teams at some point in the future, given our strategy of ten to twelve world class active investment management teams.

We have added further to our product range with the successful launch of our Global Financials Investment Trust at the beginning of July and this was followed by the launch of a Global Convertible UCITS fund in September 2013 and by a long only Biotechnology UCITS fund in November 2013.

The Company's growth rate over recent quarters has been exceptional and indeed over the last four years our AUM has increased more than fivefold. Our growth rate will undoubtedly slow over the coming quarters and years. In the very near term our growth rate will be heavily influenced by the direction of the Japanese market and fund flows into or out of our Japanese funds given the percentage of overall assets these funds now represent. Over the longer term there remains significant opportunity for further growth in assets and profits if we continue to deliver on investment performance, client service and operational excellence and if global equity markets remain supportive.

 

Tim Woolley

Chief Executive

3 December 2013

 

 

Interim Consolidated Income Statement for the six months to 30 September 2013

 

(Unaudited)

 Six months to 30 September 2013

£'000

(Unaudited)

Six months to 30 September 2012

£'000

Revenue

31,646

17,632

Finance income

231

454

Gross income

31,877

18,086

Commissions and fees payable

(2,363)

(1,419)

Net income

29,514

16,667

Operating costs before share-based payments

(18,878)

(12,047)

Operating profit before share-based payments,amortisation/impairment and tax

10,636

4,620

Share-based payments

(551)

(319)

Amortisation/impairment of intangible assets

-

(540)

Profit for the period before tax

10,085

3,761

Taxation

(2,365)

(945)

Profit for the period attributable to ordinary shareholders

7,720

2,816

Basic earnings per ordinary share

9.53p

3.64p

Diluted earnings per ordinary share

8.19p

3.17p

Adjusted earnings per ordinary share

8.77p

4.14p

 

All of the items in the above statements are derived from continuing operations.

 

Interim Consolidated Statement of Comprehensive Income for the six months to 30 September 2013

 

(Unaudited) Six months to 30 September 2013

£'000

(Unaudited)

Six months to 30 September 2012

£'000

Profit for the period attributable to ordinary shareholders

7,720

2,816

Other comprehensive income:

Net gain/(loss) on the revaluation of available-for-sale financial assets

16

(4)

Deferred tax effect

-

2

16

(2)

Net movement on the fair valuation of cash flow hedges

1,397

(175)

Deferred tax effect

(354)

34

1,043

(141)

Other comprehensive income

1,059

(143)

Total comprehensive income for the period,net of tax, attributable to ordinary shareholders

8,779

2,673

 

 

Interim Consolidated Balance Sheet as at 30 September 2013

(Unaudited)

30 September 2013

£'000

(Audited)

31 March 2013

£'000

Non-current assets

Property, plant and equipment

96

85

Deferred tax assets

6,243

4,140

Total non-current assets

6,339

4,225

Current assets

Available-for-sale financial assets

34,466

31,246

Trade and other receivables

7,636

7,216

Cash at bank and in hand

22,276

30,940

Total current assets

64,378

69,402

Total assets

70,717

73,627

Non-current liabilities

Deferred tax Liabilities

378

24

Current liabilities

Trade and other payables

11,362

16,113

Other financial liabilities

341

1,068

Current tax liabilities

1,812

2,659

Total current liabilities

13,515

19,840

Total liabilities

13,893

19,864

Net assets

56,824

53,763

Capital and reserves

Issued share capital

2,081

2,062

Share premium

16,152

16,094

Investment in own shares

(1,017)

(1,107)

Capital and other reserves

7,488

3,848

Retained earnings

32,120

32,776

Total equity - attributable to ordinary shareholders

56,824

53,763

 

Interim Consolidated Statement of Changes in Equity for the six months to 30 September 2013

Share Capital £'000

Share premium £'000

Own shares £'000

Capital reserves £'000

Other reserves £'000

Retained earnings £'000

Total equity £'000

As at 1 April 2013

2,062

16,094

(1,017)

219

3,629

32,776

53,763

Profit for the period

-

-

-

-

-

7,720

7,720

Other comprehensive income

-

-

-

-

1,059

-

1,059

Total comprehensive income

-

-

-

-

1,059

7,720

8,779

Issue of shares against options

16

58

-

-

-

(14)

60

Issue of shares on crystallisation event

3

-

-

(3)

-

-

-

Dividends paid

-

-

-

-

-

(8,913)

(8,913)

Share based payment

-

-

-

-

-

551

551

Deferred tax on share based payments

-

-

-

-

2,584

-

2,584

As at 30 September 2013 (unaudited)

2,081

16,152

(1,017)

216

7,272

32,120

56,824

As at 1 April 2012 (restated)

1,983

16,010

(1,107)

281

1,854

27,577

46,598

Profit for the period

-

-

-

-

-

2,816

2,816

Other comprehensive income

-

-

-

-

(143)

-

(143)

Total comprehensive income

-

-

-

-

(143)

2,816

2,673

Issue of shares against options

3

27

70

-

-

-

100

Issue of shares on crystallisation event

-

-

-

-

-

-

-

Dividends paid

-

-

-

-

-

(5,807)

(5,807)

Share based payment

-

-

-

-

-

319

319

Deferred tax on share based payments

-

-

-

-

205

-

205

As at 30 September 2012 (unaudited)

1,986

16,037

(1,037)

281

1,916

24,905

44,088

Interim Consolidated Statement of Cash Flow for the six months to 30 September 2013

 

(Unaudited)

Six months to 30 September 2013

£'000

(Unaudited)

Six months to 30 September 2012

£'000

Operating activities

Cash generated from/used in operations

5,073

953

Tax paid

(2,784)

(1,266)

Net cash inflow/(outflow) generated from operating activities

2,289

(313)

Investing activities

Interest received and similar income

8

5

Purchase of property, plant and equipment

(41)

(38)

Proceeds from sale of available-for-sale financial assets

21,226

4,434

Purchase of available-for-sale financial assets

(23,279)

-

Cash flows related to instruments at fair value through profit or loss

-

(49)

Cash flows related to derivatives

(28)

(87)

Net cash (outflow)/inflow from investing activities

(2,114)

4,265

Financing activities

Dividends paid

(8,913)

(5,807)

Issue of ordinary shares

74

30

Receipts in relation to investment in own shares

-

70

Net cash outflow from financing activities

(8,839)

(5,707)

Net decrease in cash and cash equivalents

(8,664)

(1,755)

Cash and cash equivalents at start of period

30,940

22,583

Cash and cash equivalents at end of period

22,276

20,828

 

 

Notes to the Unaudited Interim Condensed Consolidated Financial Statements for the six months to 30 September 2013

 

1. General Information, Basis of Preparation and Accounting Policies

Polar Capital Holdings plc ("the Company") is a public limited Company registered in England and Wales.

The unaudited interim condensed consolidated financial statements to 30 September 2013 have been prepared in accordance with IAS 34: Interim Financial Reporting.

The unaudited interim condensed consolidated financial statements do not include all the information and disclosures required in annual financial statements, and should be read in conjunction with the Group's annual financial statements as at 31 March 2013 which have been prepared in accordance with International Financial Reporting Standards (IFRS) as adopted by the European Union and the Companies Act 2006 applicable to companies reporting under IFRS.

The accounting policies adopted in the preparation of the unaudited interim condensed consolidated financial statements are consistent with those used in the preparation of the Group's annual financial statements for the year ended 31 March 2013.

 

2. Revenue

(Unaudited)

Six months to 30 September 2013

£'000

(Unaudited)

Six months to 30 September 2012

£'000

Investment management fees

31,675

17,586

Investment advisory fees

-

100

Investment performance fees

-

-

(Loss) on hedging

(29)

(54)

31,646

17,632

 

3. Profit on Ordinary Activities Before Taxation

a. This is stated after charging:

(Unaudited)

Six months to 30 September 2013

£'000

(Unaudited)

Six months to 30 September 2012

£'000

Profit on ordinary activities before taxation is stated after charging:

Staff costs

14,783

8,403

Depreciation of tangible fixed assets

29

21

Operating lease rentals - land & buildings

392

383

Operating lease rentals - other

190

203

 

b. Auditors' remuneration:

Audit of group financial statements

20

20

Other fees

- local statutory audits of subsidiaries

15

15

- tax services

-

14

- internal controls review

22

25

 

4. Dividends

(Unaudited)

Six months to 30 September 2013

£'000

(Unaudited)

Six months to 30 September 2012

£'000

Dividend paid

8,913

5,807

 

5. Earnings per Ordinary Share

The calculation of basic earnings per ordinary share is based on the profit for the period of £7,719,758 (September 2012: profit £2,815,265) and on 80,975,377 (September 2012: 77,446,648) ordinary shares, being the weighted number of ordinary shares.

The calculation of diluted earnings per ordinary share is based on the profit for the period of £7,719,758 (September 2012: profit £2,815,265) and 94,298,538 (September 2012: 88,833,779) ordinary shares, being the weighted average number of ordinary shares allowing for all options of 9,602,935 (September 2012: 6,449,376) which are dilutive as well as shares granted under a crystallisation event but not yet issued of 3,720,227 (September 2012: 4,937,756).

The calculation of adjusted earnings per ordinary share is based on a profit for the period of £7,719,758 (September 2012: profit of £2,815,265 but adjusted for the share-based payments charge of £550,900 (September 2012 share base payments charge of: £318,676, amortisation of intangibles of £428,500 and impairment of goodwill of £111,410),and 94,298,538 (September 2012: 88,833,779 ) ordinary shares being the weighted average number of ordinary shares allowing for all dilutive options and as well as shares granted under a crystallisation event but not yet issued.

6. Available-for-sale Financial Assets

(Unaudited)

Six months to 30 September 2013

£'000

(Audited)

Year to 31 March 2013

£'000

At beginning of period

31,246

26,426

Additions

23,279

33,676

Redemptions

(20,075)

(28,862)

Net gain on movement in fair value

16

6

At end of period

34,466

31,246

 

7. Notes to the Cash Flow Statement

Reconciliation of profit before taxation to cash generated from operations

(Unaudited)

Six months to 30 September 2013

£'000

(Unaudited)

Six months to 30 September 2012

£'000

Cash flows from operating activities

Profit on ordinary activities before tax

10,085

3,761

Interest received

(8)

(5)

Depreciation of tangible fixed assets

29

21

Increase in trade and other receivables

(420)

(222)

Decrease in trade and other payables

(4,751)

(3,296)

Gain on disposal of available for sale assets

(850)

(189)

Loss/(gain) on instruments at fair value through profit or loss

637

(63)

(Gain)/loss on derivatives

(200)

87

Share-based payment

551

319

Amortisation of intangibles

-

540

Cash generated from operations

5,073

953

 

8. Related Party Transactions

Transactions between the Company and its subsidiaries, which are related parties of the Company, have been eliminated on consolidation and are not included in this note.

B J D Ashford-Russell is a member of Polar Capital LLP and a director of the Polar Capital Technology Trust PLC (the Trust). Polar Capital LLP is the appointed investment manager of the Trust. The total fees received by the Group as investment manager of the Trust were £2,816,851 (September 2012: £2,606,392). The amounts receivable at period end in this respect were £994,007 (March 2013: £902,900).

At the end of the period, the Group had an outstanding loan due of £1,017,131 (March 2013: £1,017,131) from the Polar Capital Employee Benefit Trust, which was set up in 2002 to hold ordinary shares in Polar Capital Holdings plc for the benefit employees.

9. The Publication of Non-Statutory Accounts

The financial information contained in this unaudited half year report does not constitute statutory accounts as defined in S434 of the Companies Act 2006. The financial information for the six months ended 30 September 2013 and 2012 has not been audited. The information for the year ended 31 March 2013 has been extracted from the latest published audited accounts, which have been filed with the Registrar of Companies. The audited accounts filed with the Registrar of Companies contain a report of the independent auditor dated 13 June 2013. The report of the independent auditor on those financial statements contained no qualification or statement under S498 of the Companies Act 2006.

 

 

Shareholder Information

Directors

T H Bartlam Non executive Chairman

T J Woolley Chief Executive Officer

J B Mansell Chief Operating Officer

H G C Aldous Non executive director, Chairman of Audit Committee

B J D Ashford-Russell Non executive director

J M B Cayzer-Colvin Non executive director, Chairman of Remuneration Committee

G V Bumeder Non executive director

M W Thomas Non executive director

 

Dividend

A first interim dividend of 4.0p per share has been declared for the year to 31 March 2014. This will be paid on 17 January 2014 to shareholders on the register on 3 January 2014. The shares will trade ex-dividend from 31 December 2013. 

 

Half Year Report 

The Half Year report will be posted to shareholders in January 2014. Copies of this announcement and of the Half Year report will be available from the Secretary at the Registered Office, 4 Matthew Parker Street, London SW1H 9NP and from the Company's website at www.polarcapital.co.uk 

 

Remuneration Code

Disclosure of the group's Remuneration Code will be made alongside its Pillar 3 disclosure which is available on the Company's website

 

Nominated Advisorand Corporate Broker to the Company

Canaccord Genuity

 

Neither the contents of the Company's website nor the contents of any website accessible from the hyperlinks on the Company's website (or any other website) is incorporated into or forms part of this announcement.

 

 

ENDS

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IR LFFELFSLVIIV
Date   Source Headline
26th Apr 202410:33 amRNSForm 8.3 - RENALYTIX PLC
17th Apr 20243:55 pmRNSDirector/PDMR Shareholding
12th Apr 20245:43 pmRNSHolding(s) in Company
11th Apr 20247:00 amRNSAuM Update
9th Apr 20244:01 pmRNSChange of Company Secretary
15th Mar 20243:02 pmRNSForm 8.3 - Renalytix PLC
15th Mar 202410:23 amRNSForm 8.3 - Renalytix PLC - Replacement
13th Mar 20246:14 pmRNSForm 8.3 - RENALYTIX PLC
7th Mar 20244:30 pmRNSHolding(s) in Company
6th Mar 20245:47 pmRNSForm 8.3 - DIRECT LINE INSURANCE GROUP PLC
6th Mar 20245:37 pmRNSForm 8.3 - RENALYTIX PLC
27th Feb 20242:19 pmRNSForm 8.3 - Wincanton PLC
7th Feb 20242:09 pmRNSDirector/PDMR Shareholding
1st Feb 20247:00 amRNSBlock listing Interim Review
25th Jan 20244:53 pmRNSForm 8.3 -Wincanton PLC
11th Jan 20247:00 amRNSAuM Update
10th Jan 20242:54 pmRNSHolding(s) in Company
10th Jan 20242:51 pmRNSHolding(s) in Company
20th Nov 20237:00 amRNSPolar Capital Holdings Unaudited interim results
9th Nov 20237:00 amRNSInvestor Presentation covering Interim Results
26th Oct 20237:00 amRNSNotice of Interim Results
12th Oct 20237:00 amRNSAuM Update
28th Sep 20235:36 pmRNSResult of AGM
18th Aug 20234:45 pmRNSDirector/PDMR Shareholding
1st Aug 202312:05 pmRNSBlock listing Interim Review
19th Jul 20234:34 pmRNSDirector/PDMR Shareholding
18th Jul 20234:30 pmRNSDirector/PDMR Shareholding
13th Jul 202311:01 amRNSDirector/PDMR Shareholding - Replacement
13th Jul 202310:48 amRNSDirector/PDMR Shareholding
13th Jul 202310:31 amRNSDirector/PDMR Shareholding
13th Jul 20237:00 amRNSAuM Update
26th Jun 20233:34 pmRNSInvestor Presentation covering Full Year Results
26th Jun 20237:00 amRNSGroup Audited Results for year ended 31 March 2023
1st Jun 20237:00 amRNSTotal Voting Rights
25th May 202312:26 pmRNSIssue of Equity
10th May 20233:10 pmRNSDirector/PDMR Shareholding
21st Apr 20232:36 pmRNSHolding(s) in Company
14th Apr 20234:01 pmRNSDirector/PDMR Shareholding
13th Apr 20237:00 amRNSAuM Update
31st Mar 202312:23 pmRNSDirector/PDMR Shareholding
10th Mar 20233:17 pmRNSDirector/PDMR Shareholding
24th Feb 20235:18 pmRNSForm 8.3 - REDX Pharma PLC
16th Feb 20235:06 pmRNSDirector/PDMR Shareholding
7th Feb 202311:09 amRNSHolding(s) in Company
1st Feb 20237:00 amRNSBlock listing Interim Review
12th Jan 20237:00 amRNSAuM Update
30th Dec 20227:00 amRNSDirectorate Change
21st Nov 20227:00 amRNSUnaudited interim results
15th Nov 20227:00 amRNSInvestor Presentation covering Interim Results
24th Oct 20227:00 amRNSNotice of Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.